The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Seminar Title
Seminar N2: Targeted medicines in hospital pharmacy: one problem – two views?
Affiliation
Heidelberg University Hospital
Country
Germany
1. Current Status, Position
Dr Schöning is Deputy Head of Pharmacy.
2. Education
- Licensure as Pharmacist in 2000;
- 2000-present: University Hospital of Heidelberg, Pharmacy;
- Head of Oncology Pharmacy Unit together with central preparation unit of cytotoxic drugs;
- Pharmaceutical management of clinical studies phase I-III in accordance to GCP and GMP;
- Quality management representative;
- Lecturer of clinical pharmacy at the School of Pharmacy, University of Heidelberg;
- Lecturer of pharmacology at the School of Nursing;
- Since 2004: Specialist in Hospital Pharmacy (“Klinische Pharmazie”, PharmD);
- PhD (Dr. sc. hum.), 2009, University of Heidelberg. Thesis: “Antimicrobial susceptibility of clinical Group-B-streptococci isolates and molecular typing of resistant strains from two different german regions”;
- Chair of Oncology Board of the German Association of Hospital Pharmacists (ADKA)
- Vice President of the German Association of Oncology Pharmacy (DGOP)
3. Research Area
Dr Schöning is engaged in various fields of Oncology Pharmacy.
Conflict of interest: Past consultant for various pharma companies.